The National Institute on Drug Abuse (NIDA) shared this past Friday that they’re on the lookout for cannabis partners who can supply them with marijuana to research. The organization has faced ongoing criticism regarding the marijuana it uses for studies, which more closely resembles hemp than the kind of product that’s used by the majority of the population.
Shutterstock
NIDA shared a notice where they listed what they’re looking for, making it clear that the marijuana must belong to facilities that operate under the Drug Enforcement Administration (DEA) approval.
RELATED: Finally, U.S. Researchers Will Get Access to High-Quality Weed
What they’re looking for
Marijuana facilities would have to “produce or procure cannabis, cannabis extract and other cannabis-derived materials for basic and clinical research, and conduct quantitative and qualitative analysis, stability determination, and recommended storage conditions for these products for approved research.”
The organization hopes to conduct research on all cannabis compounds, from THC and CBD, to cannabinoids like CBN, CBC, CBG, and more.
Marijuana remains difficult to analyze due to its status as a Schedule I drug. But now that the plant is getting legalized across the country, it’s become increasingly important for authorities to develop a better understanding of cannabis and what it can do to the population on a long term basis.
